Tower Lab
Center for Organogenesis, Regeneration & Trauma
Department of Surgery
We currently make use of single-cell RNA sequencing, spatial transcriptomics and metabolomic studies to understand the regulatory networks governing cell fate and function. Using transgenic animal models, combined with bioinformatic approaches, our lab currently focuses on understanding the mesenchymal-immune cell interactions which occur within the stem cell niche under physiological conditions, and how these signaling cascades drive regenerative or fibrotic outcomes following injury. Understanding these divergent signaling mechanisms will hopefully help guide future therapeutic strategies to promote faithful repair of damaged tissue.
Robert Tower is an Assistant Professor in the Department of Surgery with appointments in the Center for Organogenesis Research and Trauma and the Charles and Jane Pak Center for Mineral Metabolism and Clinical Research. Dr. Tower is originally from Edmonton, AB, Canada where he obtained his BS in Molecular Genetics and his MS in Cell Biology from the University of Alberta, then later conducted his PhD in Germany at the Christian Albrechts University. Dr. Tower has conducted postdoctoral studies at the University of Pennsylvania and Johns Hopkins University. In 2021, Dr. Tower was recruited to UTSW where his lab focusses on musculoskeletal biology, understanding the complex cellular interactions which occur under physiological conditions, molecular changes which occur following injury, and how these pathways dictate regenerative or fibrotic healing outcomes. Dr. Tower is supported by grants from the National Institute of Health and the Department of Defense.
Single-cell mapping of regenerative and fibrotic healing responses after musculoskeletal injury.
Tower RJ, Bancroft AC, Chowdary AR, Barnes S, Edwards NJ, Pagani CA, Dawson LA, Levi B, 2022 Sep Stem Cell ReportsNGF-p75 signaling coordinates skeletal cell migration during bone repair.
Xu J, Li Z, Tower RJ, Negri S, Wang Y, Meyers CA, Sono T, Qin Q, Lu A, Xing X, McCarthy EF, Clemens TL, James AW, 2022 Mar Sci Adv 11 8 eabl5716Neutrophil and NETosis Modulation in Traumatic Heterotopic Ossification.
Nunez JH, Juan C, Sun Y, Hong J, Bancroft AC, Hwang C, Medrano J, Huber AK, Tower RJ, Levi B, 2023 Jun Ann SurgTppp3+ synovial/tendon sheath progenitor cells contribute to heterotopic bone after trauma.
Yea JH, Gomez-Salazar M, Onggo S, Li Z, Thottappillil N, Cherief M, Negri S, Xing X, Qin Q, Tower RJ, Fan CM, Levi B, James AW, 2023 Jul Bone Res 1 11 39NELL-1 regulates the matrisome to promote osteosarcoma progression.
Qin Q, Gomez-Salazar M, Tower RJ, Chang L, Morris CD, McCarthy EF, Ting K, Zhang X, James AW, 2022 Jun Cancer ResSystemic DKK1 neutralization enhances human adipose-derived stem cell mediated bone repair.
Negri S, Wang Y, Sono T, Qin Q, Hsu GC, Cherief M, Xu J, Lee S, Tower RJ, Yu V, Piplani A, Meyers CA, Broderick K, Lee M, James AW, 2021 Apr Stem Cells Transl Med 4 10 610-622Spatial distribution of type II collagen gene expression in the mouse intervertebral disc.
Wei Y, Tower RJ, Tian Z, Mohanraj B, Mauck RL, Qin L, Zhang Y, 2019 Dec JOR Spine 4 2 e1070Vhl deletion in osteoblasts boosts cellular glycolysis and improves global glucose metabolism.
Dirckx N, Tower RJ, Mercken EM, Vangoitsenhoven R, Moreau-Triby C, Breugelmans T, Nefyodova E, Cardoen R, Mathieu C, Van der Schueren B, Confavreux CB, Clemens TL, Maes C, 2018 03 J Clin Invest 3 128 1087-1105Quality of life, depression and dietary intake in Obstructive Sleep Apnea patients.
Stelmach-Mardas M, Mardas M, Iqbal K, Tower RJ, Boeing H, Piorunek T, 2016 Jul Health Qual Life Outcomes 1 14 111TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model.
Fritsche H, Heilmann T, Tower RJ, Hauser C, von Au A, El-Sheikh D, Campbell GM, Alp G, Schewe D, Hübner S, Tiwari S, Kownatzki D, Boretius S, Adam D, Jonat W, Becker T, Glüer CC, Zöller M, Kalthoff H, Schem C, Trauzold A, 2015 Apr Oncotarget 11 6 9502-16Mesenchymal stem cell contact promotes CCN1 splicing and transcription in myeloma cells.
Dotterweich J, Ebert R, Kraus S, Tower RJ, Jakob F, Schütze N, 2014 Jun Cell Commun Signal 12 36In vivo targeting of activated leukocytes by a ?2-integrin binding peptide.
Ranta TM, Suojanen J, Peñate-Medina O, Will O, Tower RJ, Glüer C, Kairemo K, Gahmberg CG, Koivunen E, Sorsa T, Saris PE, Reunanen J, 2014 Feb Mol Diagn Ther 1 18 39-44Be part of the great impact we're having on science and medical care across the globe. Check out our current openings!